Skip to content
PharmaManufacturingIQ

Solving the global benefit-risk assessment dilemma

Professor Sam Salek, School of Medical and Life Sciences, University of Hertfordshire, calls for a “universal framework” to speed up the disjointed decision-making process around the commissioning of new drugs

By Professor Sam Salek
Solving the global benefit-risk assessment dilemma
Published: | 3 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Professor Sam Salek, School of Medical and Life Sciences, University of Hertfordshire, calls for a “universal framework” to speed up the disjointed decision-making process around the commissioning of new drugs

Professor Sam Salek, School of Medical and Life Sciences, University of Hertfordshire

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information